ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.7512T>G (p.Phe2504Leu)

dbSNP: rs80358977
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002390189 SCV002669094 uncertain significance Hereditary cancer-predisposing syndrome 2024-04-17 criteria provided, single submitter clinical testing The p.F2504L variant (also known as c.7512T>G), located in coding exon 14 of the BRCA2 gene, results from a T to G substitution at nucleotide position 7512. The phenylalanine at codon 2504 is replaced by leucine, an amino acid with highly similar properties. In a study utilizing a bioinformatics method that integrates information about protein sequence, conservation, and structure in a protein likelihood ratio, the effect of this alteration was predicted to be neutral (Karchin R et al. Cancer Inform. 2008;6:203-16). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV004998157 SCV005625288 uncertain significance not provided 2024-04-25 criteria provided, single submitter clinical testing The BRCA2 c.7512T>G (p.Phe2504Leu) variant has been reported in the published literature as neutral in a multifactorial likelihood analysis (PMID: 19043619 (2008)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant.
Breast Cancer Information Core (BIC) (BRCA2) RCV000113771 SCV000147111 uncertain significance Breast-ovarian cancer, familial, susceptibility to, 2 2001-01-17 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.